Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

The team found most glucose-lowering treatments had no significant impact on dementia risk. However, people taking GLP-1 agonists like Ozempic and Wegovy were 45 percent less likely to develop ...

A new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss drugs like Ozempic and Wegovy, specifically for their potential to ...